Stock DIABIO DIAGONAL BIO AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Diagonal Bio AB

Equities

DIABIO

SE0015961826

Delayed Nasdaq Stockholm
Other stock markets
 09:26:00 2024-04-29 EDT 		5-day change 1st Jan Change
0.0702 SEK -6.65% Intraday chart for Diagonal Bio AB -23.70% -80.11%
04-05 Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic CI
04-05 Diagonal Bio AB Announces Successful Pilot Study Results CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Diagonal Bio AB announces outcome of rights issue
AQ
Diagonal Bio AB publish - White paper
AQ
Diagonal Bio AB strengthens its go-to-market strategy through an agreement with founding partner Johan Källstrand
AQ
The subscription period in Diagonal Bio AB rights issue commences today
AQ
Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic
AQ
Diagonal Bio AB Announces the Extension of Its Partnership with Horsholm Veterinary Clinic
CI
Diagonal Bio AB Announces Successful Pilot Study Results
CI
Diagonal Bio AB publishes a prospectus because of upcoming rights issue
AQ
Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB
AQ
Diagonal Bio Makes Interim CEO Permanent
MT
Diagonal Bio appoints Karin Wehlin as new CEO
AQ
Diagonal Bio Appoints Karin Wehlin as New CEO
CI
Notice to attend the extraordinary general meeting of Diagonal Bio AB
AQ
The Board of Directors decides on a preferential rights issue of units in order to finance future development
AQ
Diagonal Bio AB Year-end Report 2023
AQ
Diagonal Bio AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Diagonal Bio Signs Product Distribution Deal With Techtum Lab
MT
Diagonal Bio AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Diagonal Bio AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Diagonal Bio AB announced that it expects to receive SEK 1.8 million in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DIABIO Stock
  4. News Diagonal Bio AB